TRAF6 is an amplified oncogene bridging the RAS and NF-κB pathways in human lung cancer
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TRAF6 is an amplified oncogene bridging the RAS and NF-κB pathways in human lung cancer
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 121, Issue 10, Pages 4095-4105
Publisher
American Society for Clinical Investigation
Online
2011-09-12
DOI
10.1172/jci58818
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A gene expression signature of RAS pathway dependence predicts response to PI3K and RAS pathway inhibitors and expands the population of RAS pathway activated tumors
- (2010) Andrey Loboda et al. BMC Medical Genomics
- Genomic alterations of chromosome region 11p as predictive marker by array comparative genomic hybridization in lung adenocarcinoma patients
- (2010) Jae Sook Sung et al. CANCER GENETICS AND CYTOGENETICS
- Requirement of the NF-κB Subunit p65/RelA for K-Ras–Induced Lung Tumorigenesis
- (2010) Daniela S. Bassères et al. CANCER RESEARCH
- The landscape of somatic copy-number alteration across human cancers
- (2010) Rameen Beroukhim et al. NATURE
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
- (2009) David A. Barbie et al. NATURE
- Requirement for NF-κB signalling in a mouse model of lung adenocarcinoma
- (2009) Etienne Meylan et al. NATURE
- Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotype
- (2009) Daniel T Starczynowski et al. NATURE MEDICINE
- High-resolution whole genome tiling path array CGH analysis of CD34+ cells from patients with low-risk myelodysplastic syndromes reveals cryptic copy number alterations and predicts overall and leukemia-free survival
- (2008) D. T. Starczynowski et al. BLOOD
- SIGMA2: A system for the integrative genomic multi-dimensional analysis of cancer genomes, epigenomes, and transcriptomes
- (2008) Raj Chari et al. BMC BIOINFORMATICS
- The Signaling Adaptor p62 Is an Important NF-κB Mediator in Tumorigenesis
- (2008) Angeles Duran et al. CANCER CELL
- Growth Inhibition and Radiosensitization of Glioblastoma and Lung Cancer Cells by Small Interfering RNA Silencing of Tumor Necrosis Factor Receptor-Associated Factor 2
- (2008) M. Zheng et al. CANCER RESEARCH
- Integrative genomic and gene expression analysis of chromosome 7 identified novel oncogene loci in non-small cell lung cancer
- (2008) Jennifer M. Campbell et al. GENOME
- A selective small molecule inhibitor of c-Met, PHA-665752, reverses lung premalignancy induced by mutant K-ras
- (2008) Y. Yang et al. MOLECULAR CANCER THERAPEUTICS
- Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study
- (2008) Kerby Shedden et al. NATURE MEDICINE
- Lung Cancer
- (2008) Roy S. Herbst et al. NEW ENGLAND JOURNAL OF MEDICINE
- DNA amplification is a ubiquitous mechanism of oncogene activation in lung and other cancers
- (2008) W W Lockwood et al. ONCOGENE
- TRAF6 Autoubiquitination-Independent Activation of the NFκB and MAPK Pathways in Response to IL-1 and RANKL
- (2008) Matthew C. Walsh et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started